API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.fiercebiotech.com/biotech/esmo-lilly-s-ret-drug-shrinks-more-than-half-rare-thyroid-cancers
https://www.fiercebiotech.com/biotech/esmo-lilly-s-ret-drug-shrinks-more-than-half-rare-thyroid-cancers
https://www.fiercebiotech.com/biotech/asco-shrinking-60-lung-cancers-blueprint-s-ret-drug-poised-for-2020-filing
http://www.fiercepharma.com/pharma/nice-looks-to-toss-sanofi-and-ipsen-thyroid-cancer-drugs-from-cancer-drug-fund
http://www.pharmatimes.com/news/nice_rejects_thyroid_cancer_drugs_1203075
http://www.nasdaq.com/article/astrazeneca-completes-divestment-of-caprelsa-to-genzyme--quick-facts-20151007-00055?
http://www.fiercepharma.com/story/astrazeneca-tops-q2-estimates-strength-diabetes-drugs-and-clot-buster-brili/2015-07-30
http://www.businesswire.com/news/home/20150726005051/en/Genzyme-Strengthens-Endocrinology-Portfolio-Acquisition-Rare-Disease#.VbXMvtKqqko